If insurance says no to your weight loss medicine, try this : NPR

Key Points:

• Deborah Finley, a single mother with obesity-related health issues, found success with the GLP-1 drug Zepbound for weight loss and improved sleep apnea, but her insurance stopped covering it due to high costs for health plans.
• Many insurance plans are dropping coverage for GLP-1 drugs like Zepbound and Wegovy, affecting millions, but coverage may still be possible if patients have qualifying conditions such as sleep apnea, fatty liver disease, or Type 2 diabetes.
• Patients are encouraged to carefully review their insurance policies, seek prior authorizations, file appeals with support from their doctors, and maintain detailed medical records to navigate coverage denials.
• For those paying out of pocket, discount programs and health savings accounts can help offset costs, but caution is advised when considering unapproved compounded versions of GLP-1 drugs purchased online.
• Experts urge persistence in appealing insurance denials and remain optimistic that GLP-1 drugs will become more affordable over time, similar to how statins evolved from costly to widely accessible medications.